AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹3,486 Cr | ₹3,173 Cr | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr |
What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹3,486 Cr |
| Mar2024 | ₹3,173 Cr |
| Mar2023 | ₹1,928 Cr |
| Mar2022 | ₹2,648 Cr |
| Mar2021 | ₹5,335 Cr |
How is Consolidated Net Profit of AUROBINDO PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,486 Cr | 9.86 | |
| Mar2024 | ₹3,173 Cr | 64.62 | |
| Mar2023 | ₹1,928 Cr | -27.21 | |
| Mar2022 | ₹2,648 Cr | -50.36 | |
| Mar2021 | ₹5,335 Cr | - | |
Compare Consolidated Net Profit of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹65,813.4 Cr | -2.9% | -6.9% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.9% |
-6.9% |
-4.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses